Disposition of the selective α(1A)-adrenoceptor antagonist tamsulosin in humans: Comparison with data from interspecies scaling

Journal of Pharmaceutical Sciences

Volumn 86, Issue 10, 1997, Pages 1156-1161

  Van Hoogdalem, Ewoud J ^a   Soeishi, Yoshiaki ^a   Matsushima, Hiroshi ^a   Higuchi, Saburo ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 1A ADRENERGIC RECEPTOR; TAMSULOSIN; ADRENERGIC RECEPTOR ALPHA(1A); ALPHA 1 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; SULFONAMIDE;

ARTICLE; BODY WEIGHT; DOG; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISPOSITION; DRUG HALF LIFE; DRUG PROTEIN BINDING; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; RABBIT; RAT; SPECIES DIFFERENCE; SUSTAINED RELEASE PREPARATION; ANIMAL; BLOOD; COMPARATIVE STUDY; DRUG ANTAGONISM; FISCHER 344 RAT;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; DOGS; HUMANS; INFUSIONS, INTRAVENOUS; MALE; RABBITS; RATS; RATS, INBRED F344; RECEPTORS, ADRENERGIC, ALPHA-1; SPECIES SPECIFICITY; SULFONAMIDES;

EID: 0030608941     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js960303k     Document Type: Article

References (18)

1. Rabasseda, X.; Fitzpatrick, J. M. Drugs of Today 1996, 32, 259-268.
2. Soeishi, Y.; Matshushima, H.; Teraya, Y.; Watanabe, T.; Higuchi, S.; Kaniwa, H. Xenobiotica 1996, 26, 355-365.
3. Soeishi, Y.; Matshushima, H.; Watanabe, T.; Higuchi, S.; Cornelissen, K.; Ward, J. Xenobiotica 1996, 26, 637-645.
4. Soeishi, Y.; Kobori, M.; Kobayashi, S.; Higuchi, S.; Arima, H.; Sullivan, H. R.; Turner, J. C.; Esumi, Y.; Takaichi, M.; Yokota, T.; Seki, H. Pharmacometrics (Oyo Yakuri) 1990, 40, 101-109.
5. Mordenti, J. J. Pharm. Sci. 1986, 75, 1028-1040.
6. Boxenbaum, H. J. Pharmacokinet. Biopharm. 1982, 10, 201-227.
7. Boxenbaum, H.; Ronfeld, R. Am. J. Physiol. 1983, 245, R768-R774.
8. Leal, M.; Yacobi, A.; Batra, V. K. In Integration of Pharmacokinetics, Pharmacodynamics, and Toxicokinetics in Rational Drug Development; Yacobi, A., Ed.; Plenum: New York, 1993; pp 55-67.
9. Lave, T.; Coassolo, P.; Ubeaud, G.; Brandt, R.; Schmitt, C.; Dupin, S.; Jaeck, D.; Chou, R. C. Pharm. Res. 1996, 13, 97-101.
10. Chiou, W. L.; Choi, Y. M. Pharm. Res. 1995, 12, 1238-1239.
11. Schmid, B.; Bircher, J.; Preisig, R.; Kupfer, A. Clin. Pharmacol. Ther. 1985, 38, 618-624.
12. Soeishi, Y.; Kobori, M.; Kobayashi, S.; Higuchi, S. J. Chromatogr. 1990, 553, 291-296.
13. Anonymous. Siphar. An integrated computer system for pharmacokinetic data analysis, Version 4.0; SIMED: Créteail, France, 1991; p 76.
14. Chiou, W. L. J. Pharmacokinet. Biopharm. 1978, 6, 539-546.
15. Rowland, M.; Tozer, T. Clinical Pharmacokinetics, 2nd ed.; Lea & Febiger: Philadelphia, 1989; pp 303-304.
16. Metzler, C. M.; Elfring, G. L.; Macwen, A. J. Biometrics 1974, 30, 562-563.
17. Qin, M.; Nilsson, M.; Øie, S. J. Pharmacol. Exp. Ther. 1994, 269, 1176-1181.
18. Faure, C.; Gouhlier, C.; Langer, S. Z.; Graham, D. Biochem. Biophys. Res. Comm. 1995, 213, 935-943.